{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:47:42Z","timestamp":1770990462364,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12272-012-1201-9","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:19:27Z","timestamp":1356002367000},"page":"2029-2033","source":"Crossref","is-referenced-by-count":11,"title":["Identification of YH-GKA, a novel benzamide glucokinase activator as therapeutic candidate for type 2 diabetes mellitus"],"prefix":"10.1007","volume":"35","author":[{"given":"Kaapjoo","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1021\/jm900839k","volume":"52","author":"G. R. Bebernitz","year":"2009","unstructured":"Bebernitz, G. R., Beaulieu, V., Dale, B. A., Deacon, R., Duttaroy, A., Gao, J., Grondine, M. S., Gupta, R. C., Kakmak, M., Kavana, M., Kirman, L. C., Liang, J., Maniara, W. M., Munshi, S., Nadkarni, S. S., Schuster, H. F., Stams, T., St Denny, I., Taslimi, P. M., Vash, B., and Caplan, S. L., Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes. J. Med. Chem., 52, 6142\u20136152 (2009).","journal-title":"J. Med. Chem."},{"key":"1201_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","volume":"26","author":"M. J. Fowler","year":"2008","unstructured":"Fowler, M. J., Microvascular and macrovascular complications of diabetes. Clin. Diabetes, 26, 77\u201382 (2008).","journal-title":"Clin. Diabetes"},{"key":"1201_CR3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1358\/dof.2009.034.08.1394557","volume":"34","author":"M. C. T. Fyfe","year":"2009","unstructured":"Fyfe, M. C. T. and Procter, M. J., Glucokinase activators as potential antidiabetic drugs possessing superior glucoselowering efficacy. Drugs Future, 34, 641\u2013653 (2009).","journal-title":"Drugs Future"},{"key":"1201_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.1084073","volume":"301","author":"J. Grimsby","year":"2003","unstructured":"Grimsby, J., Sarabu, R., Corbett, W. L., Hayne, N. E., Bizzarro, F. T., Coffey, J. W., Guertin, K. R., Hilliard, D. W., Kester, R. F., Mahaney, P. E., Marcus, L., Qi, L.D., Soence, C. L., Tengi, J., Magnuson, M. A., Chu, C. A., Dvorozniak, M. T., Matschinsky, F. M., and Grippo, J. F., Allosteric activators of glucokinase: potential role in diabetes therapy. Science, 301, 370\u2013373 (2003).","journal-title":"Science"},{"key":"1201_CR5","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1021\/bi060253q","volume":"45","author":"W. Heredia","year":"2006","unstructured":"Heredia W., Thomson J., Nettleton D., and Sun S., Glucoseinduced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis. Biochemistry, 45, 7553\u20137562 (2006).","journal-title":"Biochemistry"},{"key":"1201_CR6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bmcl.2010.01.041","volume":"20","author":"T. Iino","year":"2010","unstructured":"Iino, T., Hashimoto, N., Hasegawa, T., Chiba, M., Eiki, J., and Nishimura, T., Metabolic activation of N-thiazol-2-yl benzamide as glucokinase activators: Impacts of glutathione trapping on covalent binding. Bioorg. Med. Chem. Lett., 20, 1619\u20131622 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1201_CR7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"S. E. Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L., and Utzschneider, K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"1201_CR8","first-page":"687","volume-title":"Joslin\u2019s Diabetes Mellitus 14th ed","author":"H. E. Lebovitz","year":"2005","unstructured":"Lebovitz, H. E., Management of hyperglycemia with oral antihyperglycemic agents in type 2 diabetes. In Joslin\u2019s Diabetes Mellitus 14th ed. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 687\u2013710, (2005)."},{"key":"1201_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.411","volume":"63","author":"M. L. Massa","year":"2011","unstructured":"Massa, M. L., Gagliardino, J. J., and Francini, F., Liver Glucokinase: An overview on the regulatory mechanisms of its activity. IUBMB Life, 63, 1\u20136 (2011).","journal-title":"IUBMB Life"},{"key":"1201_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/diabetes.45.2.223","volume":"45","author":"F. M. Matschinsky","year":"1996","unstructured":"Matschinsky, F. M., A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 45, 223\u2013241 (1996).","journal-title":"Diabetes"},{"key":"1201_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diabetes.47.3.307","volume":"47","author":"F. M. Matschinsky","year":"1998","unstructured":"Matschinsky, F. M., Glaser, B., and Magnuson, M. A., Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes, 47, 307\u2013315 (1998).","journal-title":"Diabetes"},{"key":"1201_CR12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2850","volume":"8","author":"F. Matschinsky","year":"2009","unstructured":"Matschinsky, F., Assessing the potential of glucokinase activatorsin diabetic therapy. Nat. Rev. Drug Discov., 8, 399\u2013416 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1201_CR13","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc11-1200","volume":"34","author":"G. E. Meininger","year":"2011","unstructured":"Meininger, G. E., Scott, R., Alba, R., Shentu, Y., Luo, E., Amin, H., Davies, M. J., Kaufman, K. D., and Goldstein, B. J., Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes Care, 34, 2560\u20132566 (2011).","journal-title":"Diabetes Care"},{"key":"1201_CR14","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.bmcl.2009.03.137","volume":"19","author":"M. Mitsuya","year":"2009","unstructured":"Mitsuya, M., Kamata, K., Bamba, M., Watanabe, H., Sasaki, Y., Sasaki, K., Ohyama, S., Hosaka, H., Nagata, Y., Eiki, J., and Nishimura, T., Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators. Bioorg Med Chem Lett., 19, 2718\u20132721 (2009).","journal-title":"Bioorg Med Chem Lett."},{"key":"1201_CR15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/jm2014887","volume":"55","author":"J. A. Pfefferkorn","year":"2012","unstructured":"Pfefferkorn, J. A., Guzman-Perez, A., Litchfield, J., Aiello, R., Treadway, J. L., Pettersen, J., Minich, M. L., Filipski, K. J., Jones, C. S., Tu, M., Aspnes, G., Risley, H., Bian, J., Stevens, B. D., Bourassa, P., D\u2019Aquila, T., Baker, L., Barucci, N., Robertson, A. S., Bourbonais, F., Derksen, D. R., Macdougall, M., Cabrera, O., Chen, J., Lapworth, A. L., Landro, J. A., Zavadoski, W. J., Atkinson, K., Haddish-Berhane, N., Tan, B., Yao, L., Kosa, R. E., Varma, M. V., Feng, B., Duignan, D. B., El-Kattan, A., Murdande, S., Liu, S., Ammirati, M., Knafels, J., Dasilva-Jardine, P., Sweet, L., Liras, S., and Rolph, T. P., Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido) nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. J. Med. Chem., 55, 1318\u20131333 (2012).","journal-title":"J. Med. Chem."},{"key":"1201_CR16","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2011.03.093","volume":"11","author":"K. G. Pike","year":"2011","unstructured":"Pike, K. G., Allen, J. V., Caulkett, P. W., Clarke, D. S., Donald, C. S., Fenwick, M. L., Johnson, K. M., Johnstone, C., McKerrecher, D., Rayner, J. W., Walker, R. P., and Wilson, I., Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life. Bioorg. Med. Chem. Lett., 11, 3467\u20133470 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1201_CR17","first-page":"51","volume":"4","author":"R. Sarabu","year":"2011","unstructured":"Sarabu, R., Tilley, J. W., and Grimsby, J., The discovery of piragliatin, a glucokinase activator. RSC Drug Discovery Series, 4, 51\u201370 (2011).","journal-title":"RSC Drug Discovery Series"},{"key":"1201_CR18","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.bmcl.2010.08.029","volume":"20","author":"A. Sidduri","year":"2010","unstructured":"Sidduri, A., Grimsby, J. S., Corbett, W. L., Sarabu, R., Grippo, J. F., Lou, J., Kester, R. F., Dvorozniak, M., Marcus, L., Spence, C., Racha, J. K., and Moore, D. J., 2,3-Disubstituted acrylamides as potent glucokinase activators. Bioorg. Med. Chem. Lett., 20, 5673\u20135676 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1201_CR19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1039\/c1md00092f","volume":"2","author":"M. J. Waring","year":"2011","unstructured":"Waring, M. J., Johnstone, C., McKerrecher, D., Pike, K. G., and Robb, G., Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092. Med. Chem. Commun. 2, 775\u2013779 (2011).","journal-title":"Med. Chem. Commun"},{"key":"1201_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2011.05.009","volume":"663","author":"M. S. Winzell","year":"2011","unstructured":"Winzell, M. S., Coghlan, M., Leighton, B., Frangioudakis, G., Smith, D. M., Storlien, L. H., and Ahr\u00e9n, B., Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice. Eur. J. Pharmacol., 663, 80\u201386 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"1201_CR21","unstructured":"Yi, W-H., Han, T-D., Lee, K-Y., Kim, Y-H., Jung, E-H., Lee, DH., Park, Y-H., Min, K-N., Kim, J-K., and Lee, B-K., Novel glucokinase activators and processes for the preparation thereof. WO 2011\/081280 A2 (2011)."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-1201-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-012-1201-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-1201-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:37:01Z","timestamp":1559579821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-012-1201-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s12272-012-1201-9","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}